Clinical Trials Directory

Trials / Completed

CompletedNCT02857283

Human Biological Responses to Low Level Ozone

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To investigate if low level ozone exposure will cause measurable inflammation in nasal cells.

Detailed description

Air pollutants including ozone have been implicated in affecting health outcomes. In particular, high level ozone exposure has been shown to affect pulmonary function and cause pulmonary inflammation. Troubling community-based work has implicated high ozone levels as being correlated with increased pediatric asthma emergency room visits. Because of adverse health effects, EPA standards for safe ozone levels have been set, currently at 0.07 ppm. Still, it is estimated that 100 million Americans live in areas where ozone levels periodically remain above the EPA standard. And while this EPA standard had been set based on available data, it remained unclear at the time whether naturalistic low-level ozone exposure, such as fluctuations between 0.06-0.08 ppm throughout the day, might affect health as well. This group previously examined lung function and inflammatory response in adults exposed to low-level ozone, 0.06 ppm exposure for 6.6 hours, while undergoing intermittent moderate exercise. The investigators found that in response to low-level ozone exposure (0.06 ppm) with exercise, lung function declines and neutrophilic airway inflammation is observed. What remains unclear, is whether low-level ozone alone - without exercise - will cause similar health effects. To mimic exposure to ozone on a typical summer day in a polluted city, the investigators will expose subjects to a varying level of ozone, form 0.06 ppm to 0.08 ppm, rather than a constant 0.07ppm. The variation from 0.06ppm to 0.08ppm, then back to 0.06ppm will occur each hour.

Conditions

Interventions

TypeNameDescription
OTHEROzoneParticipants will be exposed to a concentration of ozone for 6.5 hours at a concentration that varies 0.06 to 0.08
OTHERFiltered AirParticipants will be exposed to filtered clean air
DEVICEHealth and Exposure Tracker (HET)Ozone and heart rate tracker

Timeline

Start date
2017-04-22
Primary completion
2019-05-01
Completion
2019-07-01
First posted
2016-08-05
Last updated
2021-05-14
Results posted
2020-04-14

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02857283. Inclusion in this directory is not an endorsement.

Human Biological Responses to Low Level Ozone (NCT02857283) · Clinical Trials Directory